Paper17560335
Genes that distinguish physiological and pathological angiogenesis.
Seaman S and 5 others. Cancer Cell, 2007. Cited by 337 papers, by iCite.
Cite this record
ConductScience Library. Genes that distinguish physiological and pathological angiogenesis. Papers, record 17560335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17560335
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neovascularization, Pathologic | Major topic |
| Neovascularization, Physiologic | Major topic |
| Animals | |
| Antigens, CD | |
| B7 Antigens | |
| Biomarkers, Tumor | |
| Cell Line, Tumor | |
| Endothelium, Vascular | |
| Gene Expression Profiling | |
| Liver | |
| Liver Neoplasms, Experimental | |
| Liver Regeneration | |
| Mice | |
| Organ Specificity | |
| Receptors, Immunologic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01 BC010486 | Intramural NIH HHS | United States | Z01BC010486 | PubMed and NIH | NIH RePORTER |
| ZIABC010486 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01515124 | The Women In Steady Exercise Research (WISER) Survivor Trial | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17560330 | The potential of new tumor endothelium-specific markers for the development of antivascular therapy. | https://conductscience.org/library/papers/17560330 |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1723929 | Morphological analysis of neovascularization at early stages of rat splenic autografts in comparison with tumor angiogenesis. | Cell Tissue Res | 1991 | https://conductscience.org/library/papers/1723929 | PubMed |
| 2 | 2062858 | Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/2062858 | PubMed |
| 3 | 7686339 | Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis. | Am J Pathol | 1993 | https://conductscience.org/library/papers/7686339 | PubMed |
| 4 | 7512751 | Requirement of vascular integrin alpha v beta 3 for angiogenesis. | Science | 1994 | https://conductscience.org/library/papers/7512751 | PubMed |
| 5 | 8548761 | Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. | Cancer Res | 1996 | https://conductscience.org/library/papers/8548761 | PubMed |
| 6 | 9122200 | Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9122200 | PubMed |
| 7 | 9082986 | Liver regeneration. | Science | 1997 | https://conductscience.org/library/papers/9082986 | PubMed |
| 8 | 9176498 | Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. | Nat Med | 1997 | https://conductscience.org/library/papers/9176498 | PubMed |
| 9 | 9485208 | A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. | Eur J Immunol | 1998 | https://conductscience.org/library/papers/9485208 | PubMed |
| 10 | 9570800 | Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. | J Neurosci | 1998 | https://conductscience.org/library/papers/9570800 | PubMed |
| 11 | 9885575 | PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. | Mol Cell | 1998 | https://conductscience.org/library/papers/9885575 | PubMed |
| 12 | 10417778 | Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10417778 | PubMed |
| 13 | 15530405 | Apelin is a novel angiogenic factor in retinal endothelial cells. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15530405 | PubMed |
| 14 | 15558010 | Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. | Nature | 2004 | https://conductscience.org/library/papers/15558010 | PubMed |
| 15 | 15657052 | Mouse testican-2. Expression, glycosylation, and effects on neurite outgrowth. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15657052 | PubMed |
| 16 | 15796714 | Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3). | Biochem J | 2005 | https://conductscience.org/library/papers/15796714 | PubMed |
| 17 | 16061649 | Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner. | Cancer Res | 2005 | https://conductscience.org/library/papers/16061649 | PubMed |
| 18 | 16355214 | Angiogenesis as a therapeutic target. | Nature | 2005 | https://conductscience.org/library/papers/16355214 | PubMed |
| 19 | 16750822 | Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. | Dev Biol | 2006 | https://conductscience.org/library/papers/16750822 | PubMed |
| 20 | 17167064 | CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. | FASEB J | 2007 | https://conductscience.org/library/papers/17167064 | PubMed |
Cited by214
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 337 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42151504 | The vascular niche: an orchestrator of the spatiotemporal dynamics of distant metastasis. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42151504 | PubMed |
| 42078935 | Developmental and angiogenic safety profiles of novel pyridine-based chalcone. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42078935 | PubMed |
| 41997128 | Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature. | Cell | 2026 | https://conductscience.org/library/papers/41997128 | PubMed |
| 41993624 | Anti-cancer immune priming with β-radioligand therapy using a novel high affinity antibody selectively targeting the 4Ig-Isoform of B7-H3. | Theranostics | 2026 | https://conductscience.org/library/papers/41993624 | PubMed |
| 41770377 | CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/41770377 | PubMed |
| 41691491 | Selective Targeting of Tip Endothelial Cells as a Therapeutic Strategy for Tumor Angiogenesis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41691491 | PubMed |
| 41345954 | A novel immunocytokine promotes T cell- and cytokine-induced killer cell-mediated antitumor immunity via a non-MHC-restricted mechanism in glioblastoma. | J Transl Med | 2025 | https://conductscience.org/library/papers/41345954 | PubMed |
| 41317023 | Doppel as an early-stage biomarker promoting EMT and dissemination in ovarian cancers. | Int J Cancer | 2026 | https://conductscience.org/library/papers/41317023 | PubMed |
| 41073827 | B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/41073827 | PubMed |
| 39847434 | A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies. | J Clin Invest | 2025 | https://conductscience.org/library/papers/39847434 | PubMed |
| 39467936 | Expression features of targets for anti-glioma CAR-T cell immunotherapy. | J Neurooncol | 2025 | https://conductscience.org/library/papers/39467936 | PubMed |
| 39062483 | Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation. | Biomolecules | 2024 | https://conductscience.org/library/papers/39062483 | PubMed |
| 38952550 | Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature. | Front Oncol | 2024 | https://conductscience.org/library/papers/38952550 | PubMed |
| 38637557 | Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. | Blood Cancer J | 2024 | https://conductscience.org/library/papers/38637557 | PubMed |
| 38576482 | Aberrant tumor vasculature. Facts and pitfalls. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38576482 | PubMed |
| 38473402 | Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473402 | PubMed |
| 38426109 | Endothelial cells in tumor microenvironment: insights and perspectives. | Front Immunol | 2024 | https://conductscience.org/library/papers/38426109 | PubMed |
| 38327753 | B7-H3 Inhibitors in Oncology Clinical Trials: A Review. | J Immunother Precis Oncol | 2024 | https://conductscience.org/library/papers/38327753 | PubMed |
| 38322253 | An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/38322253 | PubMed |
| 38250867 | New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38250867 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17560335
GET https://conductscience.org/api/papers/v1/17560335/references?page=2